Mattia Tiboni
Overview
Explore the profile of Mattia Tiboni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perinelli D, Verboni M, Tiboni M, Doutch J, Pisani M, Domenici F, et al.
Langmuir
. 2025 Mar;
PMID: 40051256
-Acyl amino acids are biodegradable anionic amphiphilic molecules made up of linear fatty acids as hydrophobic tails and amino acids as polar heads, which are promising for their applicability in...
2.
Eugster R, Orsi M, Buttitta G, Serafini N, Tiboni M, Casettari L, et al.
J Control Release
. 2024 Nov;
376:1025-1038.
PMID: 39489466
Drug delivery systems efficiently and safely administer therapeutic agents to specific body sites. Liposomes, spherical vesicles made of phospholipid bilayers, have become a powerful tool in this field, especially with...
3.
Mihyar R, Shalmani A, Wildt V, Sheybanifard M, Wang A, May J, et al.
J Control Release
. 2024 Sep;
375:614-626.
PMID: 39316925
Controlled manufacturing and long-term stability are key challenges in the development and translation of nanomedicines. This is exemplified by the mRNA-nanoparticle vaccines against COVID-19, which require (ultra-)cold temperatures for storage...
4.
Ongoren B, Kara A, Casettari L, Tiboni M, Lalatsa A, Sanz-Perez A, et al.
Int J Pharm
. 2024 Jul;
663:124536.
PMID: 39074648
Vesicants are chemical warfare agents (CWAs) capable of causing severe skin damage and systemic toxicity. Melatonin, known for its anti-inflammatory and antioxidant properties, can mitigate the effects of these agents....
5.
Maurizii G, Valentini L, Sotgiu G, Zamboni R, Tonetti C, Vineis C, et al.
Int J Biol Macromol
. 2024 Jul;
275(Pt 2):133722.
PMID: 38977053
The valorization of discarded wool from dairy sheep breeding is a challenging issue. The most proposed strategies lie in the processing of keratin extracted from wool without reducing the molecular...
6.
Biagiotti S, Canonico B, Tiboni M, Abbas F, Perla E, Montanari M, et al.
Sci Rep
. 2024 Jun;
14(1):14610.
PMID: 38918594
Extracellular vesicles (EVs) are promising natural nanocarriers for the delivery of therapeutic agents. As with any other kind of cell, red blood cells (RBCs) produce a limited number of EVs...
7.
Arduino I, Di Fonte R, Tiboni M, Porcelli L, Serrati S, Fondaj D, et al.
Int J Pharm
. 2023 Dec;
650:123697.
PMID: 38081557
Optimizing current therapies is among next steps in metastatic melanoma (MM) treatment landscape. The innovation of this study is the design of production process by microfluidics of cell membrane (CM)-modified...
8.
Tiboni M, Astolfi P, Verboni M, Benedetti S, Giorgini E, Notarstefano V, et al.
Colloids Surf B Biointerfaces
. 2023 Nov;
232:113596.
PMID: 37918304
Lyotropic Liquid Crystalline (LLC) nanoparticles represent an emerging class of smart, biocompatible, and biodegradable systems for the delivery of drugs. Among these, structures with complex 3D architectures such as cubosomes...
9.
Khorshid S, Goffi R, Maurizii G, Benedetti S, Sotgiu G, Zamboni R, et al.
Int J Pharm
. 2023 Oct;
647:123489.
PMID: 37805150
Fungal infections of the skin, nails, and hair are a common health concern affecting a significant proportion of the population worldwide. The current treatment options include topical and systematic agents...
10.
Tiboni M, Cespi M, Casettari L, Palmieri G, Perinelli D, Bonacucina G
Eur J Pharm Sci
. 2023 Sep;
191:106599.
PMID: 37774955
Saquinavir mesylate (SQV) is a protease inhibitor commonly employed for the treatment of human immunodeficiency virus-1 infection. It is generally administered orally as tablets in combination with other antiviral drugs....